Blind Man Capital, LLC 13F Disclosure & Portfolio Data
Blind Man Capital, LLC
CIK: 0002111811
Long-term holder
Total reported value
—
Reporting period: 2026-03-31 · Number of holdings: 1
Blind Man Capital, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Stdev
—
Beta
—
Alpha
—
Max Drawdown
—
Annualized Perf
—
Batting Avg vs S&P
—
Sortino
—
Stutzer
—
Treynor
—
Sterling
—
Calmar
—
Information Ratio
—
Tracking Error
—
Stdev Down
—
Winning Months %
—
Losing Months %
—
Best 12 Months
—
Worst 12 Months
—
Efficiency Ratio
—
Sharpe
—
Stdev Sectors
—
Skewness
—
Kurtosis
—
Upside Potential
—
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
Period
Holdings
Total value
Stability
Top holdings
2026-03-31
1
—
0
2025-12-31
1
—
0
Holding changes this quarter
Position changes disclosed by Blind Man Capital, LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
What is Blind Man Capital, LLC and what type of investor is it?
Blind Man Capital, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Blind Man Capital, LLC's largest equity positions?
Based on the latest 13F filing, Blind Man Capital, LLC's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Blind Man Capital, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Blind Man Capital, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Blind Man Capital, LLC focus on?
Sector breakdown data is not yet available for Blind Man Capital, LLC. Check back after the next 13F processing cycle.